IPP Bureau

Emcure Pharmaceuticals reports Q1 FY26 consolidated PAT higher at Rs. 206.95 Cr
Emcure Pharmaceuticals reports Q1 FY26 consolidated PAT higher at Rs. 206.95 Cr

By IPP Bureau - August 11, 2025

Emcure Pharmaceuticals has reported total income of Rs. 2,104.23 crores during the period ended June 30, 2025

Wockhardt reports Q1 FY26 loss at Rs. 108 Cr
Wockhardt reports Q1 FY26 loss at Rs. 108 Cr

By IPP Bureau - August 10, 2025

Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a

Gandhar Oil Refinery (India) reports Q1 FY26 consolidated PAT lower at Rs. 26.1 Cr YoY
Gandhar Oil Refinery (India) reports Q1 FY26 consolidated PAT lower at Rs. 26.1 Cr YoY

By IPP Bureau - August 10, 2025

Divis Laboratories posts consolidated Q1 FY26 PAT of Rs. 545 Cr
Divis Laboratories posts consolidated Q1 FY26 PAT of Rs. 545 Cr

By IPP Bureau - August 10, 2025

Divi's Laboratories has reported total income of Rs. 2,529 crores during the period ended June 30, 2025

Morepen Laboratories consolidated Q1 FY26 PAT lower at Rs. 11.40 Cr
Morepen Laboratories consolidated Q1 FY26 PAT lower at Rs. 11.40 Cr

By IPP Bureau - August 10, 2025

Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025

KIMS Q1 FY26 consolidated profit slips to Rs. 78.6 Cr
KIMS Q1 FY26 consolidated profit slips to Rs. 78.6 Cr

By IPP Bureau - August 10, 2025

KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025

Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr
Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr

By IPP Bureau - August 10, 2025

Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore

Zydus receives final approval from USFDA for Prucalopride Tablets
Zydus receives final approval from USFDA for Prucalopride Tablets

By IPP Bureau - August 09, 2025

Prucalopride is prescribed for chronic idiopathic constipation

Akums reports Q1 FY26 PAT at Rs. 65 Cr
Akums reports Q1 FY26 PAT at Rs. 65 Cr

By IPP Bureau - August 09, 2025

During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals

Cupid Q1 FY26 PAT jumps 82% at Rs. 15 Cr
Cupid Q1 FY26 PAT jumps 82% at Rs. 15 Cr

By IPP Bureau - August 09, 2025

Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25

Suraksha Diagnostic reports Q1 FY26 PAT higher by 20% at Rs. 9.1 Cr
Suraksha Diagnostic reports Q1 FY26 PAT higher by 20% at Rs. 9.1 Cr

By IPP Bureau - August 09, 2025

Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr
Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr

By IPP Bureau - August 08, 2025

Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025

Sigachi begins construction work for MCC capacity expansion at Dahej
Sigachi begins construction work for MCC capacity expansion at Dahej

By IPP Bureau - August 08, 2025

With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA

Metropolis Healthcare reports Q1 FY26 PAT higher by 19% at Rs. 45 Cr
Metropolis Healthcare reports Q1 FY26 PAT higher by 19% at Rs. 45 Cr

By IPP Bureau - August 08, 2025

ekincare launches elva.AI to resolve 80% of employee healthcare queries
ekincare launches elva.AI to resolve 80% of employee healthcare queries

By IPP Bureau - August 08, 2025

Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap

Latest Stories

Interviews

Packaging